Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, and Esophageal Cancer Research and Treatment.
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
Divergent Clinical and Immunologic Outcomes Based on <i>STK11</i> Co-mutation Status in Resectable <i>KRAS-</i> Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer
Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival